Covered recipient · General Payments record
DAVID JOSEPH HUNNIUS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,095.27
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.67 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $68.58 | 3 |
| Novo Nordisk AS | $58.10 | 3 |
| GlaxoSmithKline, LLC. | $46.58 | 3 |
| DEXCOM, INC. | $24.68 | 1 |
| Lilly USA, LLC | $22.41 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.91 | 1 |
| Inari Medical, Inc. | $16.90 | 1 |
| Esperion Therapeutics, Inc. | $16.41 | 1 |
| Sumitomo Pharma America, Inc. | $16.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.91 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117282931 | CMS |
| Amgen Inc. | $33.85 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111603626 | CMS |
| Amgen Inc. | $19.82 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111603628 | CMS |
| Dexcom, Inc. | $24.68 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295069 | CMS |
| Esperion Therapeutics, Inc. | $16.41 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129439226 | CMS |
| GlaxoSmithKline, LLC. | $17.84 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116612802 | CMS |
| GlaxoSmithKline, LLC. | $14.90 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116686489 | CMS |
| GlaxoSmithKline, LLC. | $13.84 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116444918 | CMS |
| Inari Medical, Inc. | $16.90 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140110657 | CMS |
| Lilly USA, LLC | $22.41 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136129216 | CMS |
| Novo Nordisk Inc | $18.98 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995684 | CMS |
| Novo Nordisk Inc | $21.23 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097487194 | CMS |
| Novo Nordisk Inc | $17.89 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097796444 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.91 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151074678 | CMS |
| Sumitomo Pharma America, Inc. | $16.10 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148866913 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.